Cheyne Kurokawa

1.1k total citations · 1 hit paper
17 papers, 710 citations indexed

About

Cheyne Kurokawa is a scholar working on Genetics, Infectious Diseases and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Cheyne Kurokawa has authored 17 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Infectious Diseases and 7 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Cheyne Kurokawa's work include Virus-based gene therapy research (8 papers), Vector-borne infectious diseases (7 papers) and Vector-Borne Animal Diseases (7 papers). Cheyne Kurokawa is often cited by papers focused on Virus-based gene therapy research (8 papers), Vector-borne infectious diseases (7 papers) and Vector-Borne Animal Diseases (7 papers). Cheyne Kurokawa collaborates with scholars based in United States, France and Netherlands. Cheyne Kurokawa's co-authors include Evanthia Galanis, Erol Fikrig, Sukanya Narasimhan, Geoffrey E. Lynn, Utpal Pal, Ianko Iankov, Joao H. F. Pedra, Jann N. Sarkaria, Mark A. Schroeder and Andaleeb Sajid and has published in prestigious journals such as Journal of Clinical Investigation, JNCI Journal of the National Cancer Institute and Nature Reviews Microbiology.

In The Last Decade

Cheyne Kurokawa

16 papers receiving 703 citations

Hit Papers

mRNA vaccination induces tick resistance and prevents tra... 2021 2026 2022 2024 2021 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheyne Kurokawa United States 13 296 259 202 174 155 17 710
Anne Cooley United States 18 681 2.3× 431 1.7× 65 0.3× 74 0.4× 195 1.3× 28 1.0k
Yoko Ushijima Japan 14 168 0.6× 149 0.6× 90 0.4× 104 0.6× 106 0.7× 26 505
Elena Y. Dobrikova United States 24 211 0.7× 291 1.1× 422 2.1× 384 2.2× 708 4.6× 45 1.5k
Anke Brüning‐Richardson United Kingdom 18 190 0.6× 143 0.6× 66 0.3× 120 0.7× 345 2.2× 45 889
Lan He China 13 212 0.7× 92 0.4× 45 0.2× 153 0.9× 295 1.9× 35 798
Lucilla Steinaa Kenya 16 141 0.5× 210 0.8× 51 0.3× 83 0.5× 316 2.0× 45 923
H. Kuiper Netherlands 16 702 2.4× 579 2.2× 76 0.4× 77 0.4× 66 0.4× 24 1.2k
Marie Chaussepied France 17 414 1.4× 62 0.2× 41 0.2× 189 1.1× 558 3.6× 22 1.0k
María Armesto United Kingdom 17 108 0.4× 582 2.2× 111 0.5× 48 0.3× 323 2.1× 30 1.0k
Eva Maria Borst Germany 24 328 1.1× 130 0.5× 236 1.2× 203 1.2× 324 2.1× 46 1.6k

Countries citing papers authored by Cheyne Kurokawa

Since Specialization
Citations

This map shows the geographic impact of Cheyne Kurokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheyne Kurokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheyne Kurokawa more than expected).

Fields of papers citing papers by Cheyne Kurokawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheyne Kurokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheyne Kurokawa. The network helps show where Cheyne Kurokawa may publish in the future.

Co-authorship network of co-authors of Cheyne Kurokawa

This figure shows the co-authorship network connecting the top 25 collaborators of Cheyne Kurokawa. A scholar is included among the top collaborators of Cheyne Kurokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheyne Kurokawa. Cheyne Kurokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Blair, Wade, Yueh–Ming Loo, Marcus J. Bolton, et al.. (2025). FRI-288 Synthetic interferon exhibits potent antiviral activity against HBV with the potential for an improved safety profile. Journal of Hepatology. 82. S773–S773. 1 indexed citations
2.
Lynn, Geoffrey E., Jiří Černý, Cheyne Kurokawa, et al.. (2022). Immunization of guinea pigs with cement extract induces resistance against Ixodes scapularis ticks. Ticks and Tick-borne Diseases. 13(6). 102017–102017. 5 indexed citations
3.
Kurokawa, Cheyne, Abhisek Mitra, Elena Galvani, et al.. (2022). 835 AZD4820 oncolytic vaccinia virus encoding IL-12 mediates anti-tumor activity through oncolysis and tumor-specific immunity. Regular and Young Investigator Award Abstracts. A872–A872.
4.
Matias, Jaqueline, Cheyne Kurokawa, Andaleeb Sajid, et al.. (2021). Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies. Vaccine. 39(52). 7661–7668. 30 indexed citations
5.
Panagioti, Eleni, Cheyne Kurokawa, Kimberly Viker, et al.. (2021). Immunostimulatory bacterial antigen–armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy. Journal of Clinical Investigation. 131(13). 47 indexed citations
6.
Sajid, Andaleeb, Jaqueline Matias, Gunjan Arora, et al.. (2021). mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent. Science Translational Medicine. 13(620). eabj9827–eabj9827. 102 indexed citations breakdown →
7.
Narasimhan, Sukanya, Cheyne Kurokawa, Jaqueline Matias, et al.. (2020). Acquired tick resistance: The trail is hot. Parasite Immunology. 43(5). e12808–e12808. 36 indexed citations
8.
Narasimhan, Sukanya, Cheyne Kurokawa, Hüsrev Diktaş, et al.. (2020). Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistance. Ticks and Tick-borne Diseases. 11(3). 101369–101369. 36 indexed citations
9.
Kurokawa, Cheyne, Sukanya Narasimhan, Aurobind Vidyarthi, et al.. (2020). Repeat tick exposure elicits distinct immune responses in guinea pigs and mice. Ticks and Tick-borne Diseases. 11(6). 101529–101529. 25 indexed citations
10.
Iankov, Ianko, Cheyne Kurokawa, Kimberly Viker, et al.. (2020). Live Attenuated Measles Virus Vaccine Expressing Helicobacter pylori Heat Shock Protein A. Molecular Therapy — Oncolytics. 19. 136–148. 9 indexed citations
11.
Kurokawa, Cheyne, Geoffrey E. Lynn, Joao H. F. Pedra, et al.. (2020). Interactions between Borrelia burgdorferi and ticks. Nature Reviews Microbiology. 18(10). 587–600. 123 indexed citations
12.
Kurokawa, Cheyne, Ianko Iankov, & Evanthia Galanis. (2019). A key anti-viral protein, RSAD2/VIPERIN, restricts the release of measles virus from infected cells. Virus Research. 263. 145–150. 55 indexed citations
13.
Kurokawa, Cheyne, Ianko Iankov, S. Keith Anderson, et al.. (2018). Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy. JNCI Journal of the National Cancer Institute. 110(10). 1123–1132. 76 indexed citations
14.
Hardcastle, Jayson, Lisa Mills, Courtney S. Malo, et al.. (2016). Immunovirotherapy with measles virus strains in combination with anti–PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment. Neuro-Oncology. 19(4). now179–now179. 103 indexed citations
15.
Kurokawa, Cheyne, Hirosha Geekiyanage, Cory Allen, et al.. (2016). Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma. Journal of Neuro-Oncology. 131(1). 41–48. 27 indexed citations
16.
Iankov, Ianko, Cheyne Kurokawa, Antonino B. D’Assoro, et al.. (2015). Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy. Cancer Gene Therapy. 22(9). 438–444. 18 indexed citations
17.
Domingo‐Musibay, Evidio, Cory Allen, Cheyne Kurokawa, et al.. (2014). Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma. Cancer Gene Therapy. 21(11). 483–490. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026